Immunome signs deal to use Arrayjet platform in its in-house screening operations.
Sotio terminates three trials studying its IL-15 superagonist due to ‘insufficient efficacy’
Czech biotech Sotio is immediately scrapping three clinical trials of its interleukin-15 superagonist called nanrilkefusp alfa after interim data showed “insufficient efficacy.” “While we are